{
    "code": 0,
    "data": [
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of the Earnings Call for Unaudited Financial Results of quarter and nine months ended December 31 2025 is enclosed herewith.",
            "news_id": "01693110-3898-4a52-9186-d6eaccdb7556",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9090e14f-1642-45a2-b13d-218a950f9f0a.pdf",
            "news_date": "2026-02-10 16:25:01",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Results Earnings Call for Quarter and Nine Months ended on December 31 2025 is enclosed herewith.\r\n\r\nKindly take the same on record.",
            "news_id": "06afdd55-0c4a-4ec7-bcd7-1b71a8d0f845",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f43b1341-6a7f-425c-80a9-4b8b6887590c.pdf",
            "news_date": "2026-02-09 19:58:49",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result Quarter Ended On December 31 2025",
            "news_body": "Financial Results for Quarter and Nine Months ended on December 31 2025.",
            "news_id": "c8084638-719f-4afc-9820-08e4e4d03494",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7016a6c6-13cd-4728-8112-652184e7d3e3.pdf",
            "news_date": "2026-02-09 19:28:02",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30 2025 is enclosed herewith.\r\n\r\nKindly take the same on record.",
            "news_id": "b72d6096-cca5-4250-b1e3-9e209ca3a84f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea39e12f-cd9e-4ee7-8104-4c8b6a6b34ce.pdf",
            "news_date": "2025-11-18 10:48:21",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording for the Earnings Call for Unaudited Financial Results for the quarter and half year ended September 30 2025 is enclosed herewith.",
            "news_id": "2c0b56ab-c111-4dbf-89e3-0b317536f88d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18653b41-e7e7-4e7b-ad52-76255c30bdb9.pdf",
            "news_date": "2025-11-13 17:20:10",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation is enclosed herewith.",
            "news_id": "17a3f7da-4090-448d-a87d-c79968c427cc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=980590cc-304e-4c6f-a027-74dbbb48480e.pdf",
            "news_date": "2025-11-12 18:02:05",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Unaudited Financial Results for the Quarter and Half year ended September 302025 are enclosed herewith.\r\n\r\nKindly take the same on record.",
            "news_id": "dd45aad8-7e72-421d-98be-fdc552d13c81",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9f31753-611c-4ddd-80c8-a79d0253522e.pdf",
            "news_date": "2025-11-12 17:25:35",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find Transcript for the Earnings Call held on August 14 2025.",
            "news_id": "989f0707-c138-492a-8a2b-38c5bdba6000",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98638ed4-8a32-42e3-8bb4-6fe69b1ae22c.pdf",
            "news_date": "2025-08-19 14:53:23",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find attached herewith Audio Recording of the Earnings Call held today on August 14 2025",
            "news_id": "a8a7489c-7c73-434d-b883-8c9aacb90597",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e84c001f-2ff2-4023-9b5b-ac3a9933b6cd.pdf",
            "news_date": "2025-08-14 16:44:14",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter ended June 30 2025",
            "news_id": "a14adffe-c75f-4fab-a6b8-b986a7c244f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=585d7f44-4faf-41d5-ae35-e95cfbb287a2.pdf",
            "news_date": "2025-08-13 18:28:28",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Result For The Quarter Ended On June 30 2025",
            "news_body": "Unaudited Financial Results for the quarter ended June 30 2025.\r\n\r\nKindly take the same on record.",
            "news_id": "794dd689-da94-447b-930c-516aaa805dcb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d428a80-9f64-46c6-89ac-a37801df9724.pdf",
            "news_date": "2025-08-13 18:00:33",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached Earnings Call Transcript for the Earnings call held on May 28 2025 with respect to Audited Financial Results of the Company for the quarter and year ended March 31 2025.",
            "news_id": "c06c3f73-eee6-4892-92ba-9b1b854c08aa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62c18ff5-eee2-4b37-8b91-6b41787e6bb4.pdf",
            "news_date": "2025-05-31 17:14:56",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find attached Audio Recording of Earnings Call.",
            "news_id": "cdf43898-2220-463b-b6f8-4aff5983541f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d3b53f7-2555-4fb0-b5cd-b65668e75c3e.pdf",
            "news_date": "2025-05-28 14:48:52",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of Investor Presentation.",
            "news_id": "c42e467b-680e-43a3-8da4-8ddd7d3711a8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50d4116b-de86-4332-8c93-b9b8989dad88.pdf",
            "news_date": "2025-05-27 19:42:29",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Result For Quarter And Year Ended On March 31 2025",
            "news_body": "Audited Financial Results for the year ended March 31 2025",
            "news_id": "814d4fe4-42b5-4b4c-9d3d-ba62f1ea9574",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6a54abc-a2db-4bbc-9afa-ef4b859c5994.pdf",
            "news_date": "2025-05-27 18:09:03",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call for the quarter and nine months ended December 31 2024",
            "news_id": "be423253-29a4-4a03-a2fc-ce9045eb1b71",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d9a141a-aa89-4d05-aa94-5e54666c355c.pdf",
            "news_date": "2025-01-31 12:40:36",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find the attachment.",
            "news_id": "cb764e42-6141-4aea-9a14-a09fc38aebcd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c01a1a9-c171-4e0f-98a4-19c447700df9.pdf",
            "news_date": "2025-01-24 21:44:14",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Month Ended December 31 2024",
            "news_body": "As attached.",
            "news_id": "e32bf3ea-33a7-47a9-8cf8-55dde020f154",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26b06b6d-9ea1-4192-98f2-ab751ff84f68.pdf",
            "news_date": "2025-01-24 16:24:48",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attachment.",
            "news_id": "64ead9c8-698f-4b1a-ba2f-e3b73e4ceaa5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48bdf40f-f558-438d-96c9-3206b57c3bc5.pdf",
            "news_date": "2024-11-04 15:17:15",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed.",
            "news_id": "74d0d80b-e6c2-4c62-8c7c-6be196fdd8ac",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc464cb2-a0e1-4f6b-8fd0-0eace312c6aa.pdf",
            "news_date": "2024-10-28 13:52:41",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024",
            "news_body": "Please find attachemnt.",
            "news_id": "22d8ecdb-6347-4b73-9fee-53dc7c6e2125",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=915b66eb-a9ab-40a4-bfe4-5fa7a8828e05.pdf",
            "news_date": "2024-10-28 13:49:32",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find the attachment.",
            "news_id": "a7a2392c-167a-4087-b1a3-ed608e06ec18",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f79df80d-ff2b-40da-9359-0faabfb7f2a5.pdf",
            "news_date": "2024-08-19 10:34:40",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find the attachment.",
            "news_id": "b2dd0ac4-355f-47bd-a116-b504b666c732",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=77f606ae-2674-4096-b94c-b5bda1294605.pdf",
            "news_date": "2024-08-10 14:45:19",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2024",
            "news_body": "Please find the attachment.",
            "news_id": "b1866713-1899-401f-a996-36155d29d7fe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=279db8d9-d747-4564-9735-26f9906d6fde.pdf",
            "news_date": "2024-08-10 14:18:20",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attachment.",
            "news_id": "dd94dcfa-ede8-4181-ac7d-7d801849ad95",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64845815-5ac2-4c3c-b20b-438ab9f17849.pdf",
            "news_date": "2024-06-05 13:08:21",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Earning Call",
            "news_body": "Please find attached herewith Audio recording of earning call.",
            "news_id": "8e08a8f7-87e3-4e89-8edb-c51279f006e3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8817fa8d-dc3e-4788-8432-271ba5010e25.pdf",
            "news_date": "2024-05-29 15:56:08",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find the attachment.",
            "news_id": "bda280a7-3b78-429d-ab6f-bc2daf6dfcc2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50f334bb-a063-408b-a5ad-e08a42b4d7d3.pdf",
            "news_date": "2024-05-28 18:52:40",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31, 2024",
            "news_body": "Please find the attachment.",
            "news_id": "70d29c69-8b14-4536-8a2a-631caadac698",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78ede806-162e-4d25-b43f-333aa04651dd.pdf",
            "news_date": "2024-05-28 18:31:46",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find the attachment.",
            "news_id": "9a008f98-c15d-4bbb-a3ae-161c75071827",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0e8c1fc-fd56-4e33-9251-21abd087ea97.pdf",
            "news_date": "2024-02-13 11:28:22",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attachment.",
            "news_id": "b0ada8b6-8be7-4183-88c8-e0595d604107",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd06c887-1cb7-4bbc-92ee-8922102ca7f8.pdf",
            "news_date": "2024-02-07 18:04:32",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2023",
            "news_body": "Please find attachment.",
            "news_id": "a0ce1b2c-12cd-4cb9-ab1f-f5ae2128d63e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=599cf7b3-8048-4e69-8b8c-0c0b7c95e139.pdf",
            "news_date": "2024-02-07 17:44:46",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith Earning call transcript.",
            "news_id": "2e52fe34-d662-4053-8e61-93b1640ebcd2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b7c5a16-3471-4932-a4c0-8f5ab29ef970.pdf",
            "news_date": "2023-11-13 14:46:39",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Investor Presentation.",
            "news_id": "2d1e2247-f983-4293-a982-1693616c5fc4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09988bf0-906f-468b-8895-7c26efda1844.pdf",
            "news_date": "2023-11-07 17:33:55",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "Please find attachment.",
            "news_id": "e677ff88-f085-44f1-a048-ca8b50060851",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b2ece4a-67f1-4f27-80b7-cd32e0770521.pdf",
            "news_date": "2023-11-07 16:55:01",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith Earning Call Transcript.",
            "news_id": "b094985a-747e-4afe-bc16-818f733ebe56",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73f38be3-d0e7-45e1-ae7e-e832ce56f83e.pdf",
            "news_date": "2023-08-08 15:41:29",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Earnings Call",
            "news_body": "Please find enclosed audio recording of Earning Call.",
            "news_id": "481937b1-9111-4a3d-88d2-c7b56bb8acc8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee21b016-f030-46d5-a5a1-a25612a1d16c.pdf",
            "news_date": "2023-08-04 13:12:23",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Investor Presentation.",
            "news_id": "5adc823c-3b2f-414a-9504-1efc4c532810",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b59688e5-318c-4c64-a2a9-3c1a6c9c66e9.pdf",
            "news_date": "2023-08-03 18:01:16",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "Enclosing Unaudited Financial Results for the quarter ended June 30, 2023.",
            "news_id": "f5358410-6f44-42e6-85c0-7343649b3de2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d617a252-199a-49ce-83fb-f52d1f8a36e0.pdf",
            "news_date": "2023-08-03 17:35:34",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Thursday, August 3, 2023, inter-alia, has considered and approved the Unaudited Financial Results for the Quarter ended June 30, 2023.<BR> <BR> We hereby enclose the following:<BR> <BR> 1. Copy of the Unaudited Financial Results of the Company for the quarter ended June 30, 2023 along with the Limited Review report issued by Statutory Auditor;<BR> <BR>",
            "news_id": "1af40063-0b39-4df9-9bc0-5a84919bd6f7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4718a886-1fc1-4f2c-b5f4-88b5a341f0cd.pdf",
            "news_date": "2023-08-03 17:29:42",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings call held on Monday, May 29, 2023 at 11.00 A.M. IST to discuss operational and financial performance of the Company for the Fourth Quarter and Year ended of FY 2022-2023 (Q4 & FY23).",
            "news_id": "35ec0855-994c-4fcc-b9c9-1d434df28acb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4883bda2-246a-4207-aedb-0394f02dc9ed.pdf",
            "news_date": "2023-06-02 10:10:37",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Earnings Call",
            "news_body": "In accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company''s Earnings Call held today (i.e., May 29, 2023) regarding discussion on operational and financial performance for the Fourth Quarter and Year ended of FY 2022-2023 (Q4 & FY23) is available on the Company''s website.",
            "news_id": "072fe865-5e73-4230-b57c-e7aa125c3b70",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa3e8174-b7b8-4792-9fed-d6e4a2fb0751.pdf",
            "news_date": "2023-05-29 13:08:49",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Investor Presentation.",
            "news_id": "0f7610c9-5a12-436b-a739-8f32efd54822",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f6c044d-3251-4f68-a72a-feae1caf605d.pdf",
            "news_date": "2023-05-27 21:43:37",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31, 2023",
            "news_body": "Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Friday, May 26, 2023 considered and approved the Audited Financial Results for the Quarter and year ended March 31, 2023.",
            "news_id": "27713033-ca02-4c9d-a3e0-7a986d952ffe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8038c4d4-4691-4aed-ad40-558c04d9d8aa.pdf",
            "news_date": "2023-05-26 14:55:22",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings call held on Wednesday, February 15, 2023, at 11.00 A.M. IST to discuss operational and financial performance of the Company for the quarter and nine month ended December 31, 2022.",
            "news_id": "08dd6560-1256-40a0-86e8-af58af556888",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a846f30-3ba6-452c-bac1-63737c98e0af.pdf",
            "news_date": "2023-02-20 14:39:41",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Earnings Call",
            "news_body": "In accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company''s Earnings Call held today (i.e., February 15, 2023) regarding discussion on operational and financial performance for the third Quarter and nine months ended of FY 2022-2023 (Q3 & 9M FY23) is available on the Company''s website.",
            "news_id": "8296a883-4864-4e1f-afc3-45e9a2c1f6fc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55626bc7-9a1f-4339-bc11-faf53d2904e8.pdf",
            "news_date": "2023-02-15 14:11:25",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Investor Presentation.",
            "news_id": "fbc67d0b-4477-4f0c-b94f-fb274c6035d3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79289ee6-b211-4ec3-a8eb-ef14d0931059.pdf",
            "news_date": "2023-02-14 19:34:22",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2022.",
            "news_body": "We hereby enclose the following:1. Copy of the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022 along with the Limited Review report issued by Statutory Auditor;",
            "news_id": "819f694c-cf14-41ad-95b8-8f4c959a6c5f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ba7dd1b-71fc-47e8-81e0-038e2dc65c0c.pdf",
            "news_date": "2023-02-14 17:38:07",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings call held on Friday, November 11, 2022 at 4.00 P.M. IST to discuss operational and financial performance of the Company for the quarter and half year ended September 30, 2022.",
            "news_id": "bb759cec-a658-4fb1-a040-1ecd7a7c4784",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b885104f-c5fc-4c36-898d-f4fd9e7d1fab.pdf",
            "news_date": "2022-11-17 17:47:48",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of Related Party Transactions for the half year ended September 30, 2022.",
            "news_id": "502d2889-03ad-4e61-b574-13b8d156f14a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6f3ef9e-5ca2-47be-b0a9-80f4e238dbc2.pdf",
            "news_date": "2022-11-17 16:15:26",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Earnings Call",
            "news_body": "In accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company''s Earnings Call held today (i.e., November 11, 2022) regarding discussion on operational and financial performance for the Second Quarter of FY 2022-2023 (Q2) is available on the Company''s website.The recording can be accessed from the link given below:https://supriyalifescience.com/investor-relation/financial/earning-call-recordings/",
            "news_id": "d14cea9c-d031-4eb3-acb9-28e7cd885a51",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89fad0ce-8afa-48a3-bb8b-38bf2c17f2a7.pdf",
            "news_date": "2022-11-11 18:20:24",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Six Months Ended September 30, 2022 (Revised)",
            "news_body": "We hereby enclose the following:<BR> <BR> 1. Copy of the Revised Unaudited Financial Results of the Company for the quarter and six months ended September 30, 2022 along with the Limited Review report issued by Statutory Auditor;",
            "news_id": "cb11ed15-ca47-4f8e-b759-290dea30cea4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a8cd5f6-d80f-456a-9cac-b5972f231d62.pdf",
            "news_date": "2022-11-11 14:22:07",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Investor Presentation.You are requested to kindly take the same on record.",
            "news_id": "ac0324d8-41cf-4f72-96d4-3a5fae2ca90d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7eeb9c5-5519-4c0e-995a-34bd5908e7fe.pdf",
            "news_date": "2022-11-11 09:43:34",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Six Months Ended September 30, 2022 (Revised)",
            "news_body": "We hereby enclose the following:<BR> <BR> 1. Copy of the Revised Unaudited Financial Results of the Company for the quarter and six months ended September 30, 2022 along with the Limited Review report issued by Statutory Auditor; <BR>",
            "news_id": "b8d6cb41-7e6e-46e7-8143-f2ebe9478e5d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b6906f2-9f9f-4995-bbef-7aed31bea0c9.pdf",
            "news_date": "2022-11-10 20:09:06",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Six Months Ended September 30, 2022.",
            "news_body": "We hereby enclose the following:<BR> <BR> 1. Copy of the Unaudited Financial Results of the Company for the quarter and six months ended September 30, 2022 along with the Limited Review report issued by Statutory Auditor;<BR> <BR>",
            "news_id": "ac04bd14-dc4d-49cc-b267-25d67762596c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bde5e94d-64bb-4289-a2d1-cb1321da4062.pdf",
            "news_date": "2022-11-10 17:24:02",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Thursday, November 10, 2022, inter-alia, has:<BR> <BR> 1. Considered and approved the Unaudited Financial Results for the Quarter and six months ended September 30, 2022.<BR> 2. Approved appointment of M/s. DSM & Associates, Practising Company Secretaries as Secretarial Auditor for the financial year 2022-23;<BR> 3. Approved appointment of M/s. Nair's & Panicker's, Audit & Advisory Services, as Internal Auditor for the financial year 2022-23;<BR>",
            "news_id": "66682cf9-98b0-467b-be99-c33fb741ce2c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=522ab542-4d49-42d8-96b7-ddfd20fc27a3.pdf",
            "news_date": "2022-11-10 17:16:43",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings call held on Tuesday, August 16, 2022 at 3.00 P.M. IST to discuss operational and financial performance of the Company for the quarter ended June 30, 2022 (Q1 of FY 2022-23).This is for your information and records.",
            "news_id": "6cffe024-3fa2-480b-af0b-0f4017bbe604",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cec37817-13e4-4ed4-bc95-342536ee3222.pdf",
            "news_date": "2022-08-23 18:04:34",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Earnings Call",
            "news_body": "In accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company''s Earnings Call held today (i.e., August 16, 2022) regarding discussion on operational and financial performance for the First Quarter of FY 2022-2023 (Q1) is available on the Company''s website.The recording can be accessed from the link given below:https://supriyalifescience.com/investor-relation/financial/earning-call-recordings/You are requested to kindly take the same on record.",
            "news_id": "8e96051e-e5ff-4a65-8f8f-9ddeb84351aa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ae7b848-0e6d-492d-afdf-93a7f608b9a1.pdf",
            "news_date": "2022-08-16 17:48:48",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Investor Presentation. You are requested to kindly take the same on record.",
            "news_id": "c15410ee-60df-4cfd-8556-eafdfb74d967",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d40d8956-9286-4986-a339-b9b6ffa213f7.pdf",
            "news_date": "2022-08-13 14:39:31",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2022",
            "news_body": "Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Friday, August 12, 2022, inter-alia, has:<BR> <BR> 1. Considered and approved the Unaudited Financial Results for the Quarter ended June 30, 2022.<BR> 2. Recommended re-appointment of M/s. Kakaria & Associates LLP, Chartered Accountants (Firm Registration No. 104558W/W100601) as the Statutory Auditors of the Company, for second term of five years from the conclusion of the ensuing 14th AGM till the conclusion of the 19th  AGM to be held in the year 2027, subject to approval of the members at the ensuing 14th AGM..<BR>",
            "news_id": "d37316cd-fa7e-4a00-bcf4-b17da7718a23",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=295a2fbd-c4b2-406f-b9b5-9e23d6b8cece.pdf",
            "news_date": "2022-08-12 19:24:43",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Friday, August 12, 2022, inter-alia, has:<BR> 1. Considered and approved the Unaudited Financial Results for the Quarter ended June 30, 2022.<BR> 2. Recommended re-appointment of M/s. Kakaria & Associates LLP, Chartered Accountants (Firm Registration No. 104558W/W100601) as the Statutory Auditors of the Company, for second term of five years from the conclusion of the ensuing 14th AGM till the conclusion of the 19th  AGM to be held in the year 2027, subject to approval of the members at the ensuing 14th AGM..<BR>",
            "news_id": "58d830a6-0d30-4750-8534-d0a6abca85c8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2874ef68-9297-4366-922b-82bee408771b.pdf",
            "news_date": "2022-08-12 19:19:39",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings call held on Monday, May 23, 2022 at 3.30 P.M. IST to discuss operational and financial performance of the Company for the fourth quarter and year ended March 31, 2022.This is for your information and records.",
            "news_id": "a4dd1c4c-7015-424b-84a0-7523e24e9dd7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d3d9594-3217-4860-aab2-a89d8198f7cd.pdf",
            "news_date": "2022-05-27 20:20:22",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Earnings Call",
            "news_body": "In accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company''s Earnings Call held today (i.e., May 23, 2022) regarding discussion on operational and financial performance for the Fourth Quarter and Financial Year ended March 31, 2022 (Q4 and FY 2021-22) is available on the Company''s website.The recording can be accessed from the link given below:https://supriyalifescience.com/investor-relation/financial/earning-call-recordings/ Kindly take the information on record.",
            "news_id": "6df0de99-fd73-447b-8fe8-b26b0babdb7e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cbeef86-6af8-42eb-b1b3-c24166ea3a48.pdf",
            "news_date": "2022-05-23 18:44:22",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "This has a reference to our intimation letter dated May 21, 2022, wherein the Company has submitted Investor Presentation, inter-alia, to the Stock Exchanges.In connection herewith, please find enclosed herewith revised Investor presentation.You are requested to kindly take the same on record.",
            "news_id": "e91eb2ab-87e6-4e0f-bc6c-ec37ced9c621",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=934c72b2-b8dd-44ae-ad0b-43845e491116.pdf",
            "news_date": "2022-05-21 17:27:33",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Investor Presentation.You are requested to kindly take the same on record.",
            "news_id": "df3aff27-fb5e-4988-9351-57ac48f76641",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=233dd6f0-bae1-4a8f-bb7c-0b68950be365.pdf",
            "news_date": "2022-05-21 15:23:31",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31, 2022",
            "news_body": "Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Friday, May 20, 2022, inter-alia, has:<BR> <BR> 1. Considered and approved the Audited Financial Results for the Quarter and year ended March 31, 2022.<BR> 2. Recommended the Final Dividend of Rs. 0.60 per equity share (face value of Rs. 2/- each) subject to approval of shareholders in the ensuing Annual General Meeting.<BR> <BR>",
            "news_id": "42477761-c145-4816-a349-1b8c82d4b91f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fb2bc2f-dd16-4fea-aeb1-8c2f874bfd1d.pdf",
            "news_date": "2022-05-20 16:59:08",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Friday, May 20, 2022, inter-alia, has:<BR> <BR> 1. Considered and approved the Audited Financial Results for the Quarter and year ended March 31, 2022.<BR> 2. Recommended the Final Dividend of Rs. 0.60 per equity share (face value of Rs. 2/- each) subject to approval of shareholders in the ensuing Annual General Meeting.<BR> <BR> The Financials Results will be published in newspapers as required under the Listing Regulations.<BR> <BR> The Meeting of the Board of Directors of the Company commenced at 03:00 p.m. and concluded at 04:30 p.m.<BR> <BR> <BR>",
            "news_id": "e1528b85-9d2a-494d-a877-e963cd08f23a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b680f59-9344-4a30-82a0-2f3eddb5fc58.pdf",
            "news_date": "2022-05-20 16:55:33",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings call held on Friday, January 21, 2022 at 4.00 P.M. IST to discuss operational and financial performance of the Company for the quarter and nine months ended December 31, 2021 (Q3 of FY 2021-22).This intimation is also being made available on the website of the Company at:https://supriyalifescience.com/investor-relation/ Kindly take the information on record.",
            "news_id": "bc6d6046-a3f8-4014-a9df-0f333b115574",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f36fd37-4c88-43a9-b9b5-6629e3f437b5.pdf",
            "news_date": "2022-01-25 17:31:54",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Third Quarter And Nine Months Ended On December 31, 2021 (Revised)",
            "news_body": "This has reference to our letter dated January 21, 2022 regarding submission of Unaudited Financial Results for the Quarter and nine months ended December 31, 2021 pursuant to regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015.In this connection, we would like to inform that the aforesaid unaudited results submitted to stock exchanges contain clerical error caused inadvertently.Since only the Sr. No. VII & XV contains error, we affirm that there are no other changes in the  Statement of Unaudited Financial Results for the for the Quarter and nine months ended December 31, 2021. We sincerely regret the inconvenience caused in this regard.  Kindly take revised Unaudited Financial Statement on your records.",
            "news_id": "30802550-fc33-4677-a124-4ca0ce7d80b6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92d2e550-a70f-4023-a966-0a77c960e2e9.pdf",
            "news_date": "2022-01-21 16:06:26",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation. You are requested to kindly take the same on record.",
            "news_id": "638768c9-3419-4398-a536-e1d2fff2e11d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5475add-1293-4210-9c85-293bd7c06cdb.pdf",
            "news_date": "2022-01-21 13:58:59",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2021 Along With The Limited Review Report.",
            "news_body": "The Board of Directors of Company at its meeting held on January 21, 2022, has, inter alia, considered and approved the Unaudited Financial Results of the for the Quarter and nine months ended December 31, 2021 along with the Limited Review Report.<BR> <BR> Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (Listing Regulations), we are enclosing a copy of the above mentioned Unaudited Financial Results along with the Limited Review Report of the Auditors. <BR> <BR> The Financials Results will be published in newspapers as required under the Listing Regulations.<BR> <BR> The Meeting of the Board of Directors of the Company commenced at 11.30 a.m. and concluded at 12.25 p.m.<BR> <BR> Kindly take the above said information on your records.<BR>",
            "news_id": "62b796d0-181e-49cb-9bef-50c082f97a9e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44718ec8-88d6-461f-91d6-eb9842921356.pdf",
            "news_date": "2022-01-21 12:48:57",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUPRIYA",
            "disp": "Supriya Lifescience",
            "bse_code": 543434,
            "isin": "INE07RO01027",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On January 21, 2022 In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "The Board of Directors of Company at its meeting held on January 21, 2022, has, inter alia, considered and approved the Unaudited Financial Results of the for the Quarter and nine months ended December 31, 2021 along with the Limited Review Report.<BR> <BR> Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (Listing Regulations), we are enclosing a copy of the above mentioned Unaudited Financial Results along with the Limited Review Report of the Auditors. <BR> <BR> The Financials Results will be published in newspapers as required under the Listing Regulations.<BR> <BR> The Meeting of the Board of Directors of the Company commenced at 11.30 a.m. and concluded at 12.25 p.m.<BR> <BR> Kindly take the above said information on your records.<BR>",
            "news_id": "c6d073e5-6116-4f0e-8a34-12f1623e8d6b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6a1f6f5-6471-46aa-b307-dd65dedcae8b.pdf",
            "news_date": "2022-01-21 12:46:10",
            "seo": "supriya-lifescience-ltd",
            "ltp": 710.15,
            "ch": 23.199999999999932,
            "pch": 3.3772472523473223,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7390,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}